相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Tetrahydrobiopterin: biochemistry and pathophysiology
Ernst R. Werner et al.
BIOCHEMICAL JOURNAL (2011)
Heterotetrameric forms of human phenylalanine hydroxylase: Co-expression of wild-type and mutant forms in a bicistronic system
Joao Leandro et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
Molecular genetics and impact of residual in vitro phenylalanine hydroxylase activity on tetrahydrobiopterin responsiveness in Turkish PKU population
Steven F. Dobrowolski et al.
MOLECULAR GENETICS AND METABOLISM (2011)
Diagnosis, classification, and genetics of phenylketonuria and tetrahydrobiopterin (BH4) deficiencies
Nenad Blau et al.
MOLECULAR GENETICS AND METABOLISM (2011)
New insights into tetrahydrobiopterin pharmacodynamics from Pahenu1/2, a mouse model for compound heterozygous tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency
Florian B. Lagler et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Pahenu1 is a mouse model for tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency and promotes analysis of the pharmacological chaperone mechanism in vivo
Soren W. Gersting et al.
HUMAN MOLECULAR GENETICS (2010)
Phenylketonuria: a 21(st) century perspective
Francjan J. van Spronsen
NATURE REVIEWS ENDOCRINOLOGY (2010)
Expression of Tyrosine Hydroxylase Increases the Resistance of Human Neuroblastoma Cells to Oxidative Insults
Jeferson L. Franco et al.
TOXICOLOGICAL SCIENCES (2010)
What we know that could influence future treatment of phenylketonuria
C. N. Sarkissian et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2009)
The two faces of protein misfolding: gain- and loss-of-function in neurodegenerative diseases
Konstanze F. Winklhofer et al.
EMBO JOURNAL (2008)
Molecular genetics of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency
Marcel R. Zurflueh et al.
HUMAN MUTATION (2008)
Identification of pharmacological chaperones as potential therapeutic agents to treat phenylketonuria
Angel L. Pey et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Predicted effects of missense mutations on native-state stability account for phenotypic outcome in phenylketonuria, a paradigm of misfolding diseases
Angel L. Pey et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
A role for AGL ubiquitination in the glycogen storage disorders of Lafora and Cori's disease
Alan Cheng et al.
GENES & DEVELOPMENT (2007)
Efficacy of sapropterin dihydrochloride (tetrahydrobiopterin, 6R-BH4) for reduction of phenylalanine concentration in patients with phenylketonuria: a phase III randomised placebo-controlled study
Harvey L. Levy et al.
LANCET (2007)
The PAH gene, phenylketonuria, and a paradigm shift
Charles R. Scriver
HUMAN MUTATION (2007)
Administration-route and gender-independent long-term therapeutic correction of phenylketonuria (PKU) in a mouse model by recombinant adeno-associated virus 8 pseudotyped vector-mediated gene transfer
Z Ding et al.
GENE THERAPY (2006)
Analysis of the effect of tetrahydrobiopterin on PAH gene expression in hepatoma cells
C Aguado et al.
FEBS LETTERS (2006)
Stimulation of hepatic phenylalanine hydroxylase activity but not Pah-mXNA expression upon oral loading of tetrahydrobiopterin in normal mice
R Scavelli et al.
MOLECULAR GENETICS AND METABOLISM (2005)
The activity of wild-type and mutant phenylalanine hydroxylase and its regulation by phenylalanine and tetrahydrobiopterin at physiological and pathological concentrations: An isothermal titration calorimetry study
AL Pey et al.
MOLECULAR GENETICS AND METABOLISM (2005)
Wild-type phenylalanine hydroxylase activity is enhanced by tetrahydrobiopterin supplementation in vivo: an implication for therapeutic basis of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency
S Kure et al.
MOLECULAR GENETICS AND METABOLISM (2004)
Correction of kinetic and stability defects by tetrahydrobiopterin in phenylketonuria patients with certain phenylalanine hydroxylase mutations
H Erlandsen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Tetrahydrobiopterin protects phenylalanine hydroxylase activity in vivo:: Implications for tetrahydrobiopterin-responsive hyperphenylalaninemia
B Thöny et al.
FEBS LETTERS (2004)
The metabolic and molecular bases of tetrahydroblopterin-responsive phenylalanine hydroxylase deficiency
N Blau et al.
MOLECULAR GENETICS AND METABOLISM (2004)
Regulation of tetrahydrobioterin synthesis and bioavailability in endothelial cells
WJ Shi et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2004)
Mechanisms underlying responsiveness to tetrahydrobiopterin in mild phenylketonuria mutations
AL Pey et al.
HUMAN MUTATION (2004)
Dwarfism and low insulin-like growth factor-1 due to dopamine depletion in Pts-/- mice rescued by feeding neurotransmitter precursors and H4-biopterin
L Elzaouk et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
How PAH gene mutations cause hyper-phenylalanlinemia and why mechanism matters:: Insights from in vitro expression
PJ Waters
HUMAN MUTATION (2003)
Activation of phenylalanine hydroxylase:: Effect of substitutions at Arg68 and Cys237
M Thórólfsson et al.
BIOCHEMISTRY (2003)
PAHdb 2003:: What a locus-specific knowledgebase can do
CR Scriver et al.
HUMAN MUTATION (2003)
Studies on the regulatory properties of the pterin cofactor and dopamine bound at the active site of human phenylalanine hydroxylase
T Solstad et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2003)
Role of human GTP cyclohydrolase I and its regulatory protein in tetrahydrobiopterin metabolism
A Gesierich et al.
BASIC RESEARCH IN CARDIOLOGY (2003)
Conjugation of phenylalanine hydroxylase with polyubiquitin chains catalysed by rat liver enzymes
AP Doskeland et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY (2001)
Ligand binding to the inhibitory and stimulatory GTP cyclohydrolase I/GTP cyclohydrolase I feedback regulatory protein complexes
T Yoneyama et al.
PROTEIN SCIENCE (2001)
A heteroallelic mutant mouse model: A new orthologue for human hyperphenylalaninemia
CN Sarkissian et al.
MOLECULAR GENETICS AND METABOLISM (2000)
分享论文
